Physician profile
James Beckner
NPI 1215904065
$944.44
in general payments reported to CMS, 2019-2025
20 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $109 · 2021: $22.34 · 2022: $122 · 2023: $175 · 2024: $146 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $199.46 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $153.08 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $115.71 | 2022-2023 | |
| Abbvie INC. | $99.45 | 2019-2023 | Orilissa |
| Pfizer INC. | $50.69 | 2021-2025 | |
| Boston Scientific Corporation | $46.07 | 2019-2025 | General - Female Sui |
| Exeltis, USA INC. | $40.83 | 2020-2022 | |
| Allergan, INC. | $35.58 | 2019-2020 | |
| Avion Pharmaceuticals | $28.36 | 2019-2020 | |
| Axonics, INC. | $25.59 | 2024 | Bulkamid, Axonics |
| Therapeuticsmd, INC. | $25.15 | 2019-2020 | |
| Urovant Sciences INC | $16.38 | 2022 | |
| Caldera Medical, INC | $16.17 | 2025 | |
| Evofem Biosciences, INC. | $15.60 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.59 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.77 | 2025 | Jada System |
| Duchesnay USA Incorporated | $12.70 | 2019 | |
| Lupin INC. | $11.90 | 2019 | |
| Merck Sharp & Dohme LLC | $11.49 | 2019 | |
| Medtronic USA, INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Beckner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.